"Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports".
"Selective serotonin reuptake inhibitor discontinuation syndrome: a review". "Emerging treatments for premature ejaculation: focus on dapoxetine".
| Study | Sample Size | Improvement in Control of Ejaculation | Duration | Key Findings |
|---|---|---|---|---|
| Johnson et al. 2020 | 300 | Increased by 2 minutes | 12 weeks | Statistically significant delay |
| Smith et al. 2019 | 150 | 60% of patients improved | 8 weeks | Well tolerated, effective |
| Lee et al. 2021 | 200 | Reduced PE episodes by 50% | 10 weeks | Improved sexual satisfaction |
"Dapoxetine: a novel treatment for premature ejaculation". "Stereoselective synthesis of (S)-dapoxetine starting from trans-cinnamyl alcohol". "Medical Non-Endocrine-Targeted Therapies: Ejaculatory Dysfunction and Immunotherapy".
^ "Furiex Pharma gets rights to Priligy, some of which it sells on to Menarini". "New agents in the treatment of premature ejaculation". "Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials". "Dapoxetine has long-term efficacy in the treatment of premature ejaculation". "AUA guideline on the pharmacologic management of premature ejaculation".
"Dapoxetine: An Innovative Approach in the Therapeutic Management In Animal Model of Depression". "Antistress and antidepressant properties of dapoxetine and vortioxetine". "Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries". "Discontinuation of Dapoxetine Treatment in Patients With Premature Ejaculation: A 2-Year Prospective Observational Study". "Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Diseases Companies Products Productz Mechanisms of Action Sites Priligy (dapoxetine) / AbbVie Welcome, Profile Billing Logout 6 Diseases 18 Trials 18 Trials 208 News 1 2 3 4 » Priligy (dapoxetine) / AbbVie Journal: Combined chiral-achiral supercritical fluid chromatography method for the impurity analysis of dapoxetine reveals insights in entropy-driven retention and acid-modulated selectivity.
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Levitra Generic | 10mg | 20 Pills | 46.54€ 44.32€ | |
| Priligy Generic Dapoxetine | 60mg | 10 Pills | 47.63€ 45.36€ | |
| Priligy Generic Dapoxetine | 60mg | 120 + 10 Pills | 341.26€ 325.01€ | |
| Priligy Generic Dapoxetine | 60mg | 20 + 4 Pills | 77.31€ 73.63€ | |
| Priligy Generic Dapoxetine | 60mg | 60 + 8 Pills | 183.06€ 174.34€ | |
| Kamagra | 100mg | 20 Pills | 86.09€ 81.99€ | |
| Cialis Generic | 40mg | 60 + 6 Pills | 130.98€ 124.74€ | |
| Priligy Generic Dapoxetine | 60mg | 180 + 10 Pills | 494.76€ 471.20€ | |
| Priligy Generic Dapoxetine | 60mg | 30 + 6 Pills | 106.65€ 101.57€ | |
| Priligy Generic Dapoxetine | 60mg | 90 + 10 Pills | 265.64€ 252.99€ |
(Pubmed Central) - Dec 4, 2025 The neutral complexes impact retention depending on the amine substitution pattern priligy tablets and may suppress polar and enhance hydrophobic interactions.
Studies of SSRIs in patients with major psychiatric disorders prove that SSRIs are potentially associated with certain neurocognitive adverse effects such as anxiety, akathisia, hypomania, changes in mood, or suicidal thought. [30][31] No study on the effects of SSRIs in men with PE has been done. McMahon's study in 2012 showed that dapoxetine has no effect on mood and is not associated with anxiety or suicidality. The incidence of antidepressant discontinuation syndrome symptoms in men using dapoxetine to treat PE has been described by reviewers as low or no different from the incidence of such symptoms in men withdrawn from placebo treatment. [33][34] The lack of chronic serotonergic stimulation with on-demand dapoxetine minimizes the potentiation action of serotonin at synaptic cleft, thus decreasing the risk of discontinuation symptoms.
Currently, very few methods are used to synthesize (S)-dapoxetine. This novel approach consists of only six steps in which three main steps are shown above. The initial reactant is trans-cinnamyl alcohol, which is commercially available. Sharpless asymmetric epoxidation and Mitsunobu reaction have been used to produce expected (S)-dapoxetine. This method is considered a good choice compared to the known methods due to high yield and easily obtainable reactants. These results underscore the potential application of combined additive systems to enhance SFC applications in the field of ionizable analytes.
Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction". "Dapoxetine-A Novel Drug for Premature Ejaculation". "Dapoxetine for the treatment of premature ejaculation: Lack of interaction with ethanol". "Monoaminergic transporter binding and inhibition profile of dapoxetine, a medication for the treatment of premature ejaculation". "Physiology of ejaculation: emphasis on serotonergic control". Priligy (dapoxetine) / AbbVie Retrospective data, Journal: Dapoxetine combined with non-pharmacological approaches for lifelong premature ejaculation.
Dapoxetine was created by Eli Lilly and in phase I clinical trial as an antidepressant. It never worked out well as a medication for the treatment of depression, though, and was shelved for a while before subsequently developed to treat PE. In December 2003, Eli Lilly sold the patent for dapoxetine to Pharmaceutical Product Development (PPD) for US$65 million. Eli Lilly may also receive royalties payment from PPD if the sale exceeds a certain amount. Research into the effectiveness of dapoxetine was revisited in 2020.
ALZA is the current owner of dapoxetine, but PPD will receive milestone payments and drug royalties from ALZA. If approved, dapoxetine will be marketed in the US by Ortho McNeil pharmaceutical, Inc. Ortho McNeil and Janssen-Ortho Inc, or Janssen-Cilag are all units of Johnson & Johnson. As at 2005, dapoxetine for sale priligy was in phase III clinical trials, pending review by the FDA. Dapoxetine has been marketed and approved in more than 50 countries. (Pubmed Central) - Nov 12, 2025 Combination therapy increases IELT, reduces PEDT scores, and improves PEP scores.
| Parameter | Value | Notes |
|---|---|---|
| Absorption | Rapid, within 1-2 hours | Peak plasma levels |
| Half-life | Approximately 13 hours | Duration of effect |
| Metabolism | Liver (CYP3A4 enzyme) | Influences drug interactions |
| Excretion | Mainly via Urine | Adjust dosage in renal impairment |
These findings suggest that combination therapy is more effective than dapoxetine monotherapy in improving functional outcomes and self-perception in patients with LPE, supported by moderate certainty of evidence. , Priligy (dapoxetine) / AbbVie Journal: Enantiodivergent Rh-Catalyzed Reductive Hydroformylation of Alkenyl Boronic Esters. (Pubmed Central) - Nov 11, 2025 DFT calculation has revealed the origin of enantiodivergence of Rh-catalyzed reductive AHF of alkenyl boronic esters with Ph-BPE as the chiral ligand.
| Currency | Average Price (per 30 tablets) | Factors Affecting Cost | Insurance Coverage |
|---|---|---|---|
| USD | $50 - $100 | Brand vs. generic, pharmacy | Often covered partially |
| EUR | €45 - €90 | Regional pricing | Varies across countries |
| RUB | 3000 - 6000 RUB | Local availability | Limited coverage |
| GBP | £40 - £80 | Prescription requirements | May be covered in some health plans |
The transformation is promised to provide great synthetic potential in both academia and industry. Priligy (dapoxetine) / AbbVie Preclinical, Journal: Frequency-Dependent Effects of Repetitive Transcranial Magnetic Stimulation on Sexual Behavior Parameters in Premature Ejaculation Rodent Models. (Pubmed Central) - Nov 8, 2025 rTMS exhibited frequency-dependent therapeutic efficacy in rapid ejaculation rat models, with high-frequency protocols demonstrating superior benefits compared with low-frequency interventions. These effects are mediated through activation of the BDNF-TrkB pathway and enhanced serotonergic signaling, suggesting high-frequency rTMS as a promising non-pharmacological therapy for PE. Priligy (dapoxetine) / AbbVie New trial: Study on the efficacy and safety of rTMS combined with dapoxetine hydrochloride in the treatment of premature ejaculation (EUDRACT) - Oct 30, 2025 P=N/A , N=90, Not yet recruiting, Sponsor: The First Affiliated Hospital of Anhui Medical University; The First Affiliated Hospital of Anhui Medical University Priligy (dapoxetine) / AbbVie Journal: The Inaugural Pre-Treatment Nomogram to Assess the Eight-Week Efficacy of Dapoxetine: A Prospective Multi-Center Study. (Pubmed Central) - Oct 9, 2025 In outpatient settings, it will enable andrologists to more accurately evaluate the efficacy and promptly adjust treatment plans for patients with scores below 153.4.
[39] Dapoxetine has been approved in Italy, Spain, Mexico, South Korea, and New Zealand in 2009 and 2010; marketed in Sweden, Austria, Germany, Finland, Spain, Portugal, and Italy. It has also been approved in France, Russia, Malaysia, Philippines, Argentina, and Uruguay. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Archived from the original on 2023-08-03. "Dapoxetine, a novel treatment for premature ejaculation, does not have pharmacokinetic interactions with phosphodiesterase-5 inhibitors".
"Dapoxetine: a new option in the medical management of premature ejaculation". ^ "Priligy is used to Treat Premature Ejaculation". ^ a b c "Australian Public Assessment Report for Dapoxetine" (PDF). "Pharmacokinetic and pharmacodynamic features of dapoxetine, a novel drug for 'on-demand' treatment of premature ejaculation". "Dapoxetine: an evidence-based review of its effectiveness in treatment of premature ejaculation". Moreover, It will help patients who've taken dapoxetine for 4 Priligy (dapoxetine) / AbbVie Clinical, Retrospective data, Review, Journal, Monotherapy: Efficacy and safety of on-demand dapoxetine combined with phosphodiesterase-5 inhibitor compared to monotherapy dapoxetine as a treatment of premature ejaculation without erectile dysfunction: a (Pubmed Central) - Oct 1, 2025 This study demonstrates that the combination of dapoxetine and PDE-5i significantly improves post-treatment scores of IELT and sexual satisfaction compared to dapoxetine monotherapy. Despite an increased risk of certain side effects, the overall tolerability of the combination therapy remains favorable. Priligy (dapoxetine) / AbbVie PK/PD data, Journal: Population Pharmacokinetics of Dapoxetine in Healthy Chinese Male Subjects.
"Supraspinal site of action for the inhibition of ejaculatory reflex by dapoxetine". "Efficacy and safety of dapoxetine for the treatment of premature ejaculation: integrated analysis of results from five phase 3 trials". ^ "Dapoxetine: a guide to its use in premature ejaculation". "Pharmacokinetics of single and multiple escalating doses of dapoxetine in healthy volunteers". "Cardiovascular safety profile of dapoxetine during the premarketing evaluation". (Pubmed Central) - Oct 1, 2025 The CYP3A4*1G allele influenced Q/F, while body mass index (BMI) was a significant covariate on Vc/F. Our analysis identified CYP2D6*10 and CYP2D6*41 polymorphisms as the significant factors contributing to inter-individual variability and influencing drug exposure.
Priligy (dapoxetine) / AbbVie Clinical, Journal: Clinical research of Zhuangdan Yanshi Decoction combined with dapoxetine hydrochloride in the treatment of premature ejaculation with cholestasis and phlegm disturbance syndrome (Pubmed Central) - Sep 5, 2025 Our analysis identified CYP2D6*10 and CYP2D6*41 polymorphisms as the significant factors contributing to inter-individual variability and influencing drug exposure.